Melittin Selectively Reduces Tumor-Associated M2 Macrophages
Recent pharmacological investigations indicate that melittin, the primary active peptide in honeybee venom, selectively targets tumor-associated macrophages within the tumor microenvironment. Published in peer-reviewed oncological literature, this targeted approach alters … Read More